Liver resection is beneficial for patients with colorectal liver metastases and extrahepatic disease.
作者信息
Lang Hauke
机构信息
Department of General, Visceral and Transplantation Surgery, University Medical Center, Mainz, Germany.
出版信息
Ann Transl Med. 2020 Sep;8(18):1122. doi: 10.21037/atm-20-4416.
Abstract
摘要
相似文献
1
Liver resection is beneficial for patients with colorectal liver metastases and extrahepatic disease.肝切除术对患有结直肠癌肝转移和肝外疾病的患者有益。
Ann Transl Med. 2020 Sep;8(18):1122. doi: 10.21037/atm-20-4416.
2
Liver resection is beneficial for patients with colorectal liver metastases and extrahepatic disease.肝切除术对患有结直肠癌肝转移和肝外疾病的患者有益。
Ann Transl Med. 2020 Feb;8(4):109. doi: 10.21037/atm.2019.12.125.
3
Results of R0 resection for colorectal liver metastases associated with extrahepatic disease.伴有肝外疾病的结直肠癌肝转移行R0切除的结果。
Ann Surg Oncol. 2004 Mar;11(3):274-80. doi: 10.1245/aso.2004.03.085.
4
Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease.存在肝外疾病时转移性结直肠癌的肝切除术
Lancet Oncol. 2009 Aug;10(8):801-9. doi: 10.1016/S1470-2045(09)70081-6.
5
Long-term outcome of liver resection for colorectal metastases in the presence of extrahepatic disease: A multi-institutional Japanese study.存在肝外疾病的情况下结直肠转移瘤行肝切除术的长期预后：一项多机构的日本研究。
J Hepatobiliary Pancreat Sci. 2020 Nov;27(11):810-818. doi: 10.1002/jhbp.810. Epub 2020 Aug 17.
6
Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases.肝外疾病并不构成结直肠癌肝转移灶肝切除的禁忌证。
Br J Surg. 2003 May;90(5):567-74. doi: 10.1002/bjs.4071.
7
Colorectal liver metastases with extrahepatic disease--a new criteria for oncologic resection?伴有肝外疾病的结直肠癌肝转移——肿瘤切除的新标准？
J Gastrointest Cancer. 2012 Sep;43(3):502-4. doi: 10.1007/s12029-011-9278-9.
8
[Diagnosis and treatment of colorectal liver metastases - workflow].[结直肠癌肝转移的诊断与治疗——工作流程]
Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796.
9
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease.转移性结直肠癌的肝切除术：评估隐匿性不可切除疾病的风险。
J Am Coll Surg. 1999 Jan;188(1):33-42. doi: 10.1016/s1072-7515(98)00272-5.
10
Resection of Concomitant Hepatic and Extrahepatic Metastases from Colorectal Cancer - A Worthwhile Operation?结直肠癌伴肝内和肝外转移灶的切除——是一项值得开展的手术吗？
Chirurgia (Bucur). 2017 Nov-Dec;112(6):673-682. doi: 10.21614/chirurgia.112.6.673.
引用本文的文献
1
A novel nomogram on predicting extrahepatic metastasis in colorectal cancer with liver metastasis for selective application of F-FDG PET/CT.一种用于预测伴有肝转移的结直肠癌肝外转移以选择性应用F-FDG PET/CT的新型列线图。
Int J Med Sci. 2025 Jan 1;22(3):565-574. doi: 10.7150/ijms.104453. eCollection 2025.
2
Liver Resection With Extrahepatic Disease: A Population-Based Analysis of Thoughtful Selection.伴有肝外疾病的肝切除术：基于人群的审慎选择分析
J Surg Oncol. 2025 Mar;131(3):443-449. doi: 10.1002/jso.27944. Epub 2024 Oct 28.
3
A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation.钙调磷酸酶抑制剂减量可能改善肝移植术后新发结直肠癌患者的生存。
Medicina (Kaunas). 2022 Nov 29;58(12):1755. doi: 10.3390/medicina58121755.
4
Neutrophil-to-lymphocyte ratio as a prognostic factor for survival in patients with colorectal liver metastases: A systematic review.中性粒细胞与淋巴细胞比值作为结直肠癌肝转移患者生存的预后因素：一项系统评价。
World J Clin Oncol. 2022 Oct 24;13(10):822-834. doi: 10.5306/wjco.v13.i10.822.
5
[Oncological surgery in the interdisciplinary context-On the way to personalized medicine].[跨学科背景下的肿瘤外科手术——迈向个性化医疗之路]
Chirurg. 2022 Mar;93(3):234-241. doi: 10.1007/s00104-022-01614-x. Epub 2022 Feb 24.
本文引用的文献
1
Liver resection is beneficial for patients with colorectal liver metastases and extrahepatic disease.肝切除术对患有结直肠癌肝转移和肝外疾病的患者有益。
Ann Transl Med. 2020 Feb;8(4):109. doi: 10.21037/atm.2019.12.125.
2
Innovation and Future Perspectives in the Treatment of Colorectal Liver Metastases.结直肠肝转移的治疗创新与未来展望。
J Gastrointest Surg. 2020 Feb;24(2):492-496. doi: 10.1007/s11605-019-04399-3. Epub 2019 Dec 3.
3
Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases.扩展分子谱分析可改善结直肠癌肝转移切除术后的分层和生存预测。
Ann Surg. 2019 Nov;270(5):799-805. doi: 10.1097/SLA.0000000000003527.
4
Mutation Status of , and is Superior to Mutation Status of Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.对于结直肠癌肝转移切除术后的预后， 突变状态优于 突变状态。
Clin Cancer Res. 2019 Oct 1;25(19):5843-5851. doi: 10.1158/1078-0432.CCR-19-0863. Epub 2019 Jun 20.
5
Two-Stage Hepatectomy and ALPPS for Advanced Bilateral Liver Metastases: a Tailored Approach Balancing Risk and Outcome.两阶段肝切除术和联合肝脏离断和门静脉结扎的分阶段肝切除术治疗进展期双侧肝转移瘤：一种平衡风险和预后的个体化方法。
J Gastrointest Surg. 2019 Dec;23(12):2391-2400. doi: 10.1007/s11605-019-04145-9. Epub 2019 Feb 28.
6
Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.可切除结直肠癌肝转移患者肝周淋巴结转移对预后的影响。
Br J Surg. 2018 Aug;105(9):1200-1209. doi: 10.1002/bjs.10822. Epub 2018 Apr 17.
7
Is Enhanced One-Stage Hepatectomy a Safe and Feasible Alternative to the Two-Stage Hepatectomy in the Setting of Multiple Bilobar Colorectal Liver Metastases? A Comparative Analysis between Two Pioneering Centers.在多叶结直肠癌肝转移的情况下，强化一期肝切除术是否是二期肝切除术安全可行的替代方案？两个领先中心的比较分析。
Dig Surg. 2018;35(4):323-332. doi: 10.1159/000486210. Epub 2018 Feb 13.
8
Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?潜在可治愈性切除术后转移性结直肠癌中 RAS 突变的影响：转移部位重要吗？
Ann Surg Oncol. 2018 Jan;25(1):179-187. doi: 10.1245/s10434-017-6141-7. Epub 2017 Oct 25.
9
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.一线化疗联合西妥昔单抗或贝伐单抗对KRAS野生型晚期或转移性结直肠癌患者总生存期的影响：一项随机临床试验
JAMA. 2017 Jun 20;317(23):2392-2401. doi: 10.1001/jama.2017.7105.
10
Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.结直肠肝转移及合并肝外疾病患者的治愈潜力。
J Surg Oncol. 2017 Mar;115(4):488-496. doi: 10.1002/jso.24539. Epub 2017 Mar 31.
Zotero 插件